Influenza

DRI plans to demonstrate the capacity to manufacture adjuvant at large scale

IDRI receives $4m from BARDA to create adjuvant manufacturing hub

By Zachary Brennan

Seattle-based Infectious Disease Research Institute (IDRI) has received $4m in funding from the US Biomedical Advanced Research and Development Authority (BARDA) to develop an adjuvant manufacturing hub with both preclinical and clinical expertise to...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers